Clorazepate Dipotassium

   
Google
 
Web NewDrugInformation.com

Clorazepate Dipotassium


Drug - Clorazepate Dipotassium
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Clorazepate Dipotassium
Multiple ingredients are in alphabetical order.

Strength - 15MG
The potency of the active ingredient(s), Clorazepate Dipotassium. May repeat for multiple part products.

Applicant - MYLAN
The firm name holding legal responsibility for Clorazepate Dipotassium. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 071858
The FDA assigned number to Clorazepate Dipotassium. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Clorazepate Dipotassium. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 17, 1987
The date Clorazepate Dipotassium was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Clorazepate Dipotassium. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Clorazepate Dipotassium is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mylan Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Clorazepate Dipotassium.

Clorazepate Dipotassium